Stratos Wealth Partners, Ltd Reduces Stake in Johnson & Johnson in Latest 13F Filing
Stratos Wealth Partners, Ltd Reduces Stake in Johnson & Johnson in Latest 13F Filing
Stratos Wealth Partners, Ltd has made a notable adjustment to its portfolio, as revealed in its latest SEC 13F filing. The firm reported a reduction in its holdings of Johnson & Johnson (NYSE: JNJ), a leading name in the Medical Biology industry. This move reflects a strategic decision to sell shares while maintaining a consistent percentage position in the stock.
Details of the Trade
According to the filing, Stratos Wealth Partners, Ltd sold 1,880 shares of Johnson & Johnson, keeping its overall position in the stock unchanged at 0.74% of its portfolio. The market value of the remaining holdings in JNJ stands at approximately $25.22 million. Despite the reduction, the firm continues to hold a small fraction of Johnson & Johnson's outstanding shares, accounting for 0.01% of total shares in the company.
Why is Stratos Wealth Partners Adjusting Its Position in Johnson & Johnson?
Johnson & Johnson, a stalwart in the Medical Biology sector, has long been a favorite among institutional investors due to its robust dividend history and market leadership. However, Stratos Wealth Partners' decision to sell shares could be attributed to portfolio rebalancing strategies, sector rotation, or profit-taking amid the stock's performance. Investors often monitor such moves to gauge sentiment and potential shifts in market outlook.
How Much of Johnson & Johnson Does Stratos Wealth Partners Own?
Post-sale, Stratos Wealth Partners, Ltd still holds a significant investment in Johnson & Johnson, with a market value of $25.22 million. This represents 0.74% of the firm's overall portfolio and 0.01% of Johnson & Johnson's total outstanding shares.
Portfolio Impact
The reduction in Johnson & Johnson shares does not significantly alter Stratos Wealth Partners' portfolio concentration. At 0.74%, JNJ remains a key position, showcasing the firm's continued confidence in the company's long-term prospects despite the recent sale.
For a deeper dive into Stratos Wealth Partners, Ltd's investment strategies and historical 13F filings, view their full real-time portfolio here.